dividends
McKesson Corp, Walgreens Boots Alliance, Cardinal Health Corp., CVS Health Corp: Medical Distributors an Industry on Sale
2019-05-29
Introduction This is a follow-up to my first article in a continuing series where I will be identifying and presenting dividend growth stocks for an above-average long-term total return objective. My first article in this series covered AmerisourceBergen, a leading medical distributor that I presented as significantly undervalued. However, I offer this follow-up to illustrate […]
Invest in AmerisourceBergen for its Growth and Valuation – Speculate in a Potential Takeover
2019-05-22
Introduction This is the first in a continuing series where I identify and present dividend growth stocks for an above-average long-term total return objective. Throughout this series I will be illustrating that there are several prudent sources of long-term return and there is also luck or chance. Personally, I suggest that investors strive to build […]
3M: Finally, a Great Dividend Growth Company Becoming a Good Investment!
2019-05-16
Introduction 3M I find it serendipitous that after just completing a 19-part series on how highly valued the general market is, I get the pause that refreshes. Now please don’t read more into my words than are being offered. I still believe that the market at large is fully valued. Consequently, finding great companies at […]
Slim Pickens in the Utilities Sector: Part 19
2019-05-08
Introduction This is part 19 and the final part of my series covering all the various sectors reported by FactSet. However, the popular idea of saving the best for last does not apply in this instance. As I indicated throughout each installment, there were some sectors that I felt offered better investment opportunities than others. […]
Undervalued Growth and Dividend Growth in Health Technology: Part 11
2019-03-19
Introduction Although many Health Technology Sector companies have significantly outperformed the market on a long-term basis, they have significantly underperformed the market since the beginning of 2015. With only a few minor exceptions, this is true for most companies, especially the pharmaceutical companies, operating in this sector. On the other hand, there are several examples […]